HK1126689A1 - Use of therapeutic human albumin for the preparation of a drug for the treatment of patients suffering from cognitive disorders - Google Patents

Use of therapeutic human albumin for the preparation of a drug for the treatment of patients suffering from cognitive disorders

Info

Publication number
HK1126689A1
HK1126689A1 HK09105923.2A HK09105923A HK1126689A1 HK 1126689 A1 HK1126689 A1 HK 1126689A1 HK 09105923 A HK09105923 A HK 09105923A HK 1126689 A1 HK1126689 A1 HK 1126689A1
Authority
HK
Hong Kong
Prior art keywords
drug
preparation
treatment
patients suffering
human albumin
Prior art date
Application number
HK09105923.2A
Other languages
English (en)
Original Assignee
Grifols Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Grifols Sa filed Critical Grifols Sa
Publication of HK1126689A1 publication Critical patent/HK1126689A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/38—Albumins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
HK09105923.2A 2007-10-26 2009-07-02 Use of therapeutic human albumin for the preparation of a drug for the treatment of patients suffering from cognitive disorders HK1126689A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES200702831A ES2332846B1 (es) 2007-10-26 2007-10-26 Utilizacion de albumina humana terapeutica para la preparacion de un medicamento para el tratamiento de pacientes afectados por desordenes cognitivos.

Publications (1)

Publication Number Publication Date
HK1126689A1 true HK1126689A1 (en) 2009-09-11

Family

ID=40583637

Family Applications (1)

Application Number Title Priority Date Filing Date
HK09105923.2A HK1126689A1 (en) 2007-10-26 2009-07-02 Use of therapeutic human albumin for the preparation of a drug for the treatment of patients suffering from cognitive disorders

Country Status (17)

Country Link
US (1) US7851446B2 (de)
EP (1) EP2111868B1 (de)
JP (1) JP5437619B2 (de)
CN (1) CN101417123B (de)
AR (1) AR068901A1 (de)
AU (1) AU2008233025B8 (de)
BR (1) BRPI0804623B8 (de)
CA (1) CA2641830C (de)
CL (1) CL2008003133A1 (de)
ES (2) ES2332846B1 (de)
HK (1) HK1126689A1 (de)
MX (1) MX2008013635A (de)
NZ (1) NZ572131A (de)
PL (1) PL2111868T3 (de)
PT (1) PT2111868E (de)
RU (1) RU2414925C2 (de)
UY (1) UY31418A1 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5843345B2 (ja) 2010-07-08 2016-01-13 旭化成メディカル株式会社 β−アミロイド除去システム
UA126232C2 (uk) * 2016-08-18 2022-09-07 Алкахест, Інк. Спосіб лікування когнітивного розладу, пов'язаного зі старінням, та набір, що містить фракцію плазми крові
EA039316B1 (ru) * 2016-10-24 2022-01-12 Алкахест, Инк. Фракции плазмы крови в качестве лечения когнитивных расстройств, связанных со старением
US11040068B2 (en) 2017-04-26 2021-06-22 Alkahest, Inc. Dosing regimen for treatment of cognitive and motor impairments with blood plasma and blood plasma products
EP4299129A3 (de) 2017-04-26 2024-03-20 Alkahest, Inc. Dosierschema zur behandlung von kognitiven störungen mit blutplasmaprodukten
WO2020018343A1 (en) * 2018-07-20 2020-01-23 Alkahest, Inc. Dosing regimen for treatment of cognitive and motor impairments with blood plasma and blood plasma products
EP3643319A1 (de) * 2018-10-25 2020-04-29 Grifols Worldwide Operations Limited Verwendung eines niedervolumigen plasmaaustausches zur behandlung von morbus alzheimer in frühen und mittleren stadien
AU2019364271A1 (en) 2018-10-26 2021-06-03 Alkahest, Inc. Use of plasma and plasma fractions for improvement of pain, wound healing, and postoperative recovery
JP2024516390A (ja) * 2021-04-30 2024-04-15 グリフォルス・ワールドワイド・オペレーションズ・リミテッド 認知機能障害を処置するための治療的血漿交換及び低体積血漿交換の使用

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3612137A1 (de) 1986-04-10 1987-10-15 Biotest Pharma Gmbh Steriles plasmaaustauschmittel
US5112298A (en) 1990-06-25 1992-05-12 Baxter International Inc. Apheresis method and device
US5178603A (en) 1990-07-24 1993-01-12 Baxter International, Inc. Blood extraction and reinfusion flow control system and method
US6627151B1 (en) * 1997-06-13 2003-09-30 Helmut Borberg Method for treatment diseases associated with a deterioration of the macrocirculation, microcirculation and organ perfusion
AU2001264801A1 (en) 2000-05-23 2001-12-03 The University Of Southern California Diagnosis of alzheimer's disease ldl receptor protein-1
EP1370240A4 (de) * 2001-03-02 2004-09-22 Neuron Therapeutics Inc Neuroprotektor-formulierungen und verfahren
WO2003051374A2 (en) 2001-12-17 2003-06-26 New York State Office Of Mental Health SEQUESTRATION OF Aβ IN THE PERIPHERY IN THE ABSENCE OF IMMUNOMODULATING AGENT AS A THERAPEUTIC APPROACH FOR THE TREATMENT OR PREVENTION OF BETA-AMYLOID RELATED DISEASES
CA2500952C (en) 2002-10-04 2011-04-26 Prana Biotechnology Limited Neurologically-active compounds
AU2003303198A1 (en) * 2002-12-19 2004-07-14 New York University Method for treating amyloid disease
JP2006517938A (ja) 2003-02-13 2006-08-03 オクタファルマ アクチェン ゲゼルシャフト アルブミン溶液およびその調製のための製法
JP2007528857A (ja) 2003-07-11 2007-10-18 ミリアド ジェネティクス， インコーポレイテッド アルツハイマー病の処置のための薬学的方法、投与レジメンおよび投薬形態
AT413336B (de) * 2003-09-12 2006-02-15 Mattner Frank Dr Apherese-vorrichtung
US20050182044A1 (en) 2004-02-17 2005-08-18 Bruinsma Gosse B. Combinatorial therapy with an acetylcholinesterase inhibitor and (3aR)-1,3a,8-trimethyl-1,2,3,3a,8,8a-hexahydropyrrolo[2,3,-b]indol-5-yl phenylcarbamate
AT500483B1 (de) 2004-07-13 2006-01-15 Mattner Frank Dr Set zur vorbeugung oder behandlung der alzheimer'schen erkrankung
US7436304B1 (en) 2005-07-19 2008-10-14 Visible Assets, Inc Evidence tracking

Also Published As

Publication number Publication date
AU2008233025B8 (en) 2013-07-25
RU2414925C2 (ru) 2011-03-27
PL2111868T3 (pl) 2014-01-31
US20090111740A1 (en) 2009-04-30
CL2008003133A1 (es) 2009-08-07
PT2111868E (pt) 2013-10-17
ES2332846A1 (es) 2010-02-12
BRPI0804623B1 (pt) 2020-02-11
JP5437619B2 (ja) 2014-03-12
AU2008233025A1 (en) 2009-05-14
CA2641830C (en) 2013-07-16
BRPI0804623A2 (pt) 2009-06-30
JP2009108059A (ja) 2009-05-21
CN101417123A (zh) 2009-04-29
BRPI0804623B8 (pt) 2021-05-25
CN101417123B (zh) 2012-06-27
UY31418A1 (es) 2009-05-29
NZ572131A (en) 2010-06-25
ES2332846B1 (es) 2010-07-08
AU2008233025B2 (en) 2013-06-27
MX2008013635A (es) 2009-05-11
ES2428698T3 (es) 2013-11-08
AR068901A1 (es) 2009-12-16
RU2008141076A (ru) 2010-04-27
EP2111868B1 (de) 2013-08-21
CA2641830A1 (en) 2009-04-26
EP2111868A1 (de) 2009-10-28
US7851446B2 (en) 2010-12-14

Similar Documents

Publication Publication Date Title
HK1126689A1 (en) Use of therapeutic human albumin for the preparation of a drug for the treatment of patients suffering from cognitive disorders
EP2166837A4 (de) Wirkstoffkombination zur behandlung von hauterkrankungen
TWI372056B (en) Novel medicament combinations for the treatment of respiratory diseases
IL217901B (en) Use of laquinimod or a laquinimod salt in the manufacture of a drug for the treatment of bdnf-related diseases
IL188204A0 (en) Combination therapy for the treatment of immunoinflammatory disorders
ZA200808758B (en) Combination therapy for treatment of patients with neurological disorders and cerebral infarction
IL213407A (en) Use of combinations of drug factors to prepare combination therapy drugs
AP2037A (en) Use of substituted quinoline derivatives for the treatment of drug resistant mycobacterial diseases
IL184425A0 (en) Cxcr4 antagonists for the treatment of medical disorders
IL182105A0 (en) Use of memantine for the preparation of a medicament for the treatment of childhood behavioral disorders
ZA200703601B (en) Medicaments for the treatment or prevention of fibriotic diseases
SG10201606441SA (en) Improved modalities for the treatment of degenerative diseases of the retina
HK1258028A1 (zh) 人類抗體及其在神經疾病治療中的診斷和治療用途
IL190652A0 (en) Novel pharmaceutical combinations for the treatment of respiratory disorders
UA81573C2 (en) Use of agomelatine for the preparation of medicaments for the treatment of sleep disorders in depressed patients
TWI369988B (en) New pharmaceutically active compounds for the treatment of respiratory diseases
IL206435A0 (en) Therapeutic regimens for the treatment of immunoinflammatory disorders
ME01951B (de) Verwendung des Agomelatins zur Herstellung eines Medikamentes zur Behandlung der bipolaren Erkrankungen
EP2203174A4 (de) Therapeutische schemata zur behandlung von immunentzündlichen erkrankungen
GB0428218D0 (en) Medicament for Treatment of Inflammatory Diseases
IL207977A0 (en) Therapy for disorders of the proximal digestive tract
HRP20040104A2 (en) Use of benzonaphthoazulenes for the manufacture of pharmaceutical formulations for the treatment and prevention of central nervous system diseases and disorders
EP2168575A4 (de) Medikament zur behandlung von an durch erhöhte monoaminooxidase-aktivität hervorgerufenen krankheiten leidenden patienten und verfahren zur behandlung von an durch erhöhte monoaminooxidase-aktivität hervorgerufenen krankheiten leidenden patienten
IL186916A0 (en) Use of insp052 polypeptide for the preparation of a medicament for treating diseases
GB0417474D0 (en) Treatment of respiratory disorders